Mesoblast
MESO
#4320
Rank
C$3.37 B
Marketcap
C$26.18
Share price
4.36%
Change (1 day)
70.72%
Change (1 year)

Revenue for Mesoblast (MESO)

Revenue in 2022: C$10.6 Million

According to Mesoblast 's latest financial reports the company's current revenue (TTM ) is C$10.6 Million. In 2022 the company made a revenue of C$10.6 Million a decrease over the revenue in the year 2021 that were of C$12.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Mesoblast from 2015 to 2022

Annual revenue

Year Revenue Change
2022C$10.6 M-15.85%
2021C$12.59 M-39.44%
2020C$20.8 M-24.63%
2019C$27.59 M27.52%
2018C$21.64 M7.88%
2017C$20.06 M-53.13%
2016C$42.8 M28.92%
2015C$33.19 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
C$0.19 B 1,717.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas